Epidermal Growth Factor Receptor Mutation Status and the Impact on Clinical Outcomes in Patients with Non-Small Cell Lung Cancer
Epidermal growth factor receptor (EGFR) mutation status differs according to ethnicity, gender, smoking history, and histology types. The present study aimed to evaluate EGFR mutation status in patients with non-small cell lung cancer (NSCLC) and further explore its association with clinical charact...
Main Authors: | Huang HM, Wei Y, Wang JJ, Ran FY, Wen Y, Chen QH, Zhang BF |
---|---|
Format: | Article |
Language: | English |
Published: |
Sciendo
2022-12-01
|
Series: | Balkan Journal of Medical Genetics |
Subjects: | |
Online Access: | https://doi.org/10.2478/bjmg-2022-0015 |
Similar Items
-
Prevalence of Epidermal Growth Factor Receptor Mutations in Patients with Non-Small Cell Lung Cancer in Turkish Population
by: Gaye Güler Tezel, et al.
Published: (2017-12-01) -
Protein expression, gene amplification, epidermal growth factor receptor mutations and lung carcinoma
by: Panjković Milana, et al.
Published: (2014-01-01) -
A rare epidermal growth factor receptor (EGFR) gene mutation in small cell lung carcinoma patients
by: Cheng-Cheng Hwang, et al.
Published: (2022-09-01) -
Reporting of Incidence and Outcome of Bone Metastases in Clinical Trials Enrolling Patients with Epidermal Growth Factor Receptor Mutated Lung Adenocarcinoma—A Systematic Review
by: Anita Brouns, et al.
Published: (2021-06-01) -
Almonertinib plus chemotherapy versus almonertinib alone in second-line treatment of advanced non-small cell lung cancer with mutated epidermal growth factor receptor: a retrospective study
by: Xiaoxu Fang, et al.
Published: (2023-09-01)